New Delhi: AAP MLA Atishi Tuesday(May 18) stated Delhi is left with solely three days’ stock of Covishield vaccine for the 18-44 age group, and if extra doses usually are not equipped the vaccination drive for this class will have to be stopped within the metropolis.
Delhi’s stock of Covaxin — the second coronavirus vaccine in use within the nation — for this age group has already ended, main the AAP authorities to shut vaccination centres administering Bharat Biotech-made jabs to this class of beneficiaries.
Delhi’s Vaccination Bulletin for 18th May. pic.twitter.com/3KRqdE7gfF
— Atishi (@AtishiAAP) May 18, 2021
Releasing the town’s newest “vaccination bulletin”, Atishi stated the town will have solely three days of Covishield stock left for the 18-44 age group after Tuesday night.
“We appeal to the Central government to make more vaccines available for this category immediately, else we might have to stop vaccinating this group next week,” she stated.
However, she added Delhi acquired 60,240 Covaxin doses for these aged above 45, healthcare and frontline staff on Tuesday.
But for this class too, she stated, the town has now two days of Covaxin stock left, whereas Covishield doses can final up to 4 days. However, she added, the variety of “walk-in” centres for this age group will likely be elevated within the coming days.
The Centre has been offering doses for these above 45 years and all healthcare and frontline staff throughout India. States have been allowed to procure and vaccinate these between 18-44 years beginning May 1.
Atishi additionally stated that 1.13 lakh beneficiaries acquired jabs on May 17. Around 10.75 lakh folks have acquired each doses for the reason that inoculation drive started on January 16.
A complete of 46.94 lakh doses have been administered in Delhi to this point, in accordance to the “vaccination bulletin” launched by the federal government.
(inputs from PTI)